Risk for adverse maternal outcomes among women with chronic hypertension. (14th February 2023)

• Record Type: Journal Article
• Authors: Yang, Lanbo; Friedman, Alexander M.; Krenitsky, Nicole M.; Wen, Timothy; D'Alton, Mary E.; Wright, Jason D.; Booker, Whitney; Huang, Yongmei
• Is Part Of: BJOG. Volume 130:Number 6(2023)
• Page Start: 621
• Page End: 635
• Publication Date: 2023-02-14
• Subjects: epidemiology: general obstetrics -- medical disorders in pregnancy; Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1111/1471-0528.17382
• Languages: English
• ISSNs: 1470-0328

Abstract

Abstract: Objective: To determine whether longitudinal health data accounts for end‐organ injury or death in the setting of chronic hypertension. Design: Cohort of 64 799 deliveries to 61 854 women. Setting: US claims data for the preiod 2008–2019. Population: Women with a delivery hospitalisation and chronic hypertension. Methods: Risk for a composite of acute end‐organ injury or death during the delivery hospitalisation and 30 days postpartum was analysed. Adjusted logistic regression models were derived with discrimination for each model estimated by the C ‐statistic. Poisson regression was used to estimate adjusted risk ratios. Starting with models using data from pregnancy, further adjustment was performed accounting for healthcare use in the year prior to pregnancy, including hospitalisations, emergency department encounters, prescription medications and pre‐pregnancy diagnoses. Main outcome measures: Acute end‐organ injury or death. Results: The composite outcome occurred among 5.7% of 64 799 deliveries. For patients with commercial insurance, filling non‐hypertensive medications from ≥11 different classes, compared with none (adjusted risk ratio, aRR 4.07, 95% CI 2.86–5.79), three or more hospitalisations before pregnancy, compared with none (aRR 4.75, 95% CI 3.46–6.52), and chronic kidney disease diagnosed in the year before pregnancy (aRR 2.35, 95% CI 1.88, 2.94) were associated with increased risk. For pregnancies covered by commercial insurance, the C ‐statistic increased from 0.615 (95% CI 0.599–0.630) in the model with pregnancy data only to 0.796 (95% CI 0.783–0.808) for the model additionally including healthcare use in the year before pregnancy. Findings with Medicaid were similar. Conclusions: Prepregnancy care use predicted adverse maternal outcomes. These data may be important in risk stratification.